Erasca Correlations
ERAS Stock | USD 3.28 0.01 0.31% |
The current 90-days correlation between Erasca Inc and Keros Therapeutics is 0.32 (i.e., Weak diversification). The correlation of Erasca is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Erasca Correlation With Market
Significant diversification
The correlation between Erasca Inc and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and DJI in the same portfolio, assuming nothing else is changed.
Erasca |
Moving together with Erasca Stock
0.73 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
0.61 | ANIK | Anika Therapeutics | PairCorr |
0.82 | IRMD | Iradimed Earnings Call This Week | PairCorr |
0.61 | ITGR | Integer Holdings Corp | PairCorr |
0.69 | OFIX | Orthofix Medical | PairCorr |
0.84 | SGHT | Sight Sciences Earnings Call This Week | PairCorr |
0.75 | AAC | AAC Holdings | PairCorr |
0.7 | MDH | MDH Acquisition Corp | PairCorr |
0.78 | APAC | Stonebridge Acquisition Symbol Change | PairCorr |
0.76 | ARTE | Artemis Strategic | PairCorr |
0.66 | TRCA | Twin Ridge Capital | PairCorr |
Moving against Erasca Stock
0.62 | ALVO | Alvotech | PairCorr |
0.54 | ONCT | Oncternal Therapeutics | PairCorr |
0.51 | MRK | Merck Company Earnings Call This Week | PairCorr |
0.51 | IMMP | Immutep Ltd ADR Earnings Call This Week | PairCorr |
0.5 | ENTX | Entera Bio | PairCorr |
0.49 | TARA | Protara Therapeutics Earnings Call This Week | PairCorr |
0.47 | ATHE | Alterity Therapeutics | PairCorr |
0.35 | NPCE | Neuropace | PairCorr |
0.63 | CVI | CVR Energy Earnings Call This Week | PairCorr |
0.56 | LION | Lionsgate Studios Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Erasca Stock performing well and Erasca Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Erasca's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IPSC | 4.56 | (0.20) | 0.00 | 2.17 | 0.00 | 11.11 | 30.97 | |||
NGM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
KROS | 2.28 | (0.15) | 0.00 | (0.03) | 0.00 | 6.08 | 16.46 | |||
GLUE | 4.01 | (0.29) | 0.00 | (0.07) | 0.00 | 8.36 | 24.79 | |||
GRCL | 5.71 | 1.36 | 0.19 | 1.73 | 6.35 | 16.34 | 52.11 | |||
THRX | 5.44 | (0.75) | 0.00 | (0.20) | 0.00 | 11.75 | 90.33 | |||
DSGN | 3.58 | 0.62 | 0.16 | 0.70 | 3.30 | 8.19 | 37.04 | |||
EWTX | 2.99 | 0.39 | 0.08 | 3.92 | 3.64 | 6.29 | 15.05 | |||
CCCC | 3.73 | (0.19) | (0.01) | 0.01 | 4.34 | 11.08 | 23.76 | |||
MLYS | 2.45 | 0.21 | 0.07 | 0.27 | 2.80 | 4.90 | 16.39 |
Erasca Corporate Management
Esq JD | General Secretary | Profile | |
Michael Varney | Scientific Development | Profile | |
Chandra Lovejoy | VP Affairs | Profile | |
Lisa TesvichBonora | Chief Officer | Profile | |
Nik Chetwyn | VP Operations | Profile | |
CPA MS | VP Fin | Profile | |
Wei MD | Chief Officer | Profile |